chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Runny nose; Eyes full of tears; Fever; Little hives inside her nose; Headache; This is a spontaneous report from a contactable consumer (patient herself) via Medical Information Team. A 56-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 27Apr2021 as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Enquired that, the caller requested a translator. Stated that, the caller got her first Pfizer covid vaccine on 27Apr2021 and three days later, on an unspecified date in 2021, the patient was experiencing a runny nose, eyes full of tears, little hives inside her nose, fever and headache but the headache was gone. Was this a side effect, should she call her doctor. The caller stated that, she already reported this to the safety. The outcome of the events for headache was recovered on an unspecified date in 2021 while for the other events was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Information has been received from a physician concerning an 8 year old female pt who on 08/27/03 was vaccinated with a second dose of MMRII. It was reported that the pt wiggled and some of the vaccine went into her "subdermal space" rather than the SC area of her left arm. Concomitant therapy included a dose of varicella virus vaccine live, DTP (manufacturer unknown) and IPV (manufacturer unknown). It was reported that "prior" to the MMRII vaccination, the pt received tuberculin purified protein derivative (manufacturer unknown) (A TB test) and became very frightened. No further information was provided. Unspecified medical attention was sought. Additional information has been requested.
slight headache; little fatigue; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 22Mar2021, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 19Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "in a lot of pain due to his torn left knee that needs the surgery" (unspecified if ongoing), notes: notified in November 2020 that he will need a left knee replacement; "has titanium in his back" (unspecified if ongoing), notes: before having the vaccines; "right knee replacement surgery (artificial right knee)" (unspecified if ongoing), notes: before having the vaccines. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), administration date: 27Feb2021, for COVID-19 Immunisation. The following information was reported: HEADACHE (non-serious) with onset 22Mar2021, outcome "unknown", described as "slight headache"; FATIGUE (non-serious) with onset 22Mar2021, outcome "unknown", described as "little fatigue".  Additional Information: The patient was asking when was the best time for him to get blood work done in preparation for a left knee replacement surgery. He was asking if he needed to wait for another 14 days. The patient was notified in November 2020 that he will need a knee replacement. Consequently, the patient was in a lot of pain that he was complaining about due to his torn left knee that needs the surgery. The patient mentioned that it was causing him trouble in his daily activities and that he needs an urgent answer to his questions so that he could schedule his left knee replacement surgery.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
arm was a little sore; This spontaneous report was received from a lawyer and the approximately 76-year-old female patient who was also a nurse. The patient was non-smoker. The patient's medical history included chickenpox and seizure disorder. Historical drugs included phenytoin sodium. Concomitant medications could not be determined.  In 2012, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (manufacturer unknown) (strength, lot #, expiration date, dosage, anatomical location and route of administration were not provided) for prophylaxis.  On an unspecified date, his arm was a little sore (pain in extremity). The patient also experienced herpes zoster, postherpetic neuralgia, vaccination failure and others after vaccination with zoster vaccine live (ZOSTAVAX) (case # 1306USA014036), reported as part of a litigation process.  The outcome of the event was not reported.  The reporter considered pain in extremity to be an adverse reaction or side effect of Pneumococcal Vaccine, Polyvalent (23-valent) (manufacturer unknown).; Sender's Comments:  US-009507513-1306USA014036:
On 3/28/18, patient comes in to the pharmacy to complain about adverse reactions from the SHINGRIX vaccine administered on the 23rd. Patient complained of redness, tender, and soreness on the left shoulder around the injection site. She also complained of the site being "hot" in temperature and a rash that developed 5 days later. She also stated of weakness of the entire left arm for up to 2 days after the shot. Patient also complained of 'left side reactions': Headache only on left side of head, left leg weakness, and L facial pain.
No adverse effect were noted; The expired VAQTA that was administered both had the same lot number and expiration date; This spontaneous report was received from a nurse and refers to a 2-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 03-MAY-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) , prefilled syringe, lot #T033304, expiration date: 02-APR-2022 (PT: Expired product administered) (strength, dose and route of administration were not provided) administered as prophylaxis. No adverse effects were noted. No additional information was provided.  This is a case of two from the same reporter. ; Sender's Comments:  US-009507513-2205USA005543:
VOMITING NOS; INFLUENZA LIKE ILLNESS; NAUSEA. Information has been received from a registered nurse concerning a 32 year old white male a history of a rash from penicillin and no other listed past medical history or known drug allergies who on 13-JUN-2003 at 09:00 Am was vaccinated IM in the right deltoid with a first 0.5ml dose of hepatitis b virus vaccine rHBsAg (yeast) (Lot #:644384/ D986M). There was no listed illness at the time of the vaccination. Concomitant therapy included venlafaxine HCl (EFFEXOR). On 13JUN2003, a few hours after vaccination, the patient developed nausea and vomiting and "had to leave work". The reporter indicated that several other people were vaccinated with a dose of hepatitis b virus vaccine rHBsAg (yeast) (lot # 644384/0986M) and "they did not report any problems". No lab diagnostics studies were performed. Unspecified medical attention was sought. There was no product quality complaint. There were no relevant diagnostic tests or laboratory data reported. Follow up information indicated that the patient received the vaccination per employer requirement. Approximately 2 hours after injection, on 13JUN03 at "9AM" the patient complained of nausea and vomiting. The patient was excused from work and he did not seek further medical treatment. The patient reported that the next day he felt he had the "flu", as other members of his family had been ill with signs and symptoms of the flue. The patient has since received the second doe of the vaccination without any adverse reaction. The outcome was reported as recovered. No further information is expected.
Hepatitis B given at hospital on 10/16/02. Developed left facial nerve problem on 11/5/02. Then he was given HB -HIb + DPTA on 12/12/02. Right sided facial nerve paralysis developed on 12/29/02. HIB + IPV on 10/16/03 and he developed left sided facial nerve paralysis on 11/15/03. Patient had recurrent facial paralysis start up on left side on 11/16/2004 and then progressed to right side, In this episode he did not receive any vaccine prior to this. He is being worked up for other etiologies of this recurrent episodes of facial paralysis by ENT, allergist, neurologist at Hospital.
Moderna Vaccine and swollen neck glands/lymphedema:  I am writing to let VAERS professionals know that I had the Moderna vaccines and STILL have swollen glands after the last shot on April 3rd, 2021.    I also have lymphedema caused by my lymph system being compromised due to having breast cancer surgeries, radiation, breast reconstruction. abdominal adhesions, etc.   First Shot:  Moderna Lot # 011A21A, March 6th, 2021  Second Shot:  Moderna Lot #019B21A, April 3rd, 2021  I am looking forward to receiving a booster shot(s) however it is very likely that I will request to have the shot in my thigh.  I spoke to my breast cancer surgeon/specialist about this and she agreed.  https://www.ctvnews.ca/health/coronavirus/why-some-people-might-want-to-get-a-covid-19-shot-in-their-thigh-instead-of-their-arm-1.5418725  Thank you for the opportunity to share this information.
On Tuesday February 2, 2021, my son slept at my house (not at his group home apartment) and complained of severe headache and neck pain. His whole body was in pain as well. His blood pressure was 150/90. On Wednesday, February 22 he slept at his group home apartment and complained on chills, body pain and headache. He cancelled that day his counseling session and work. He called me on Thursday still complaining of body aches and weakness. He stayed in bed till Friday February 5, 2021.  He has been taking pain killers all this time.
T 98.4 Vaccine was administered on 5/23/2017. He woke up on 5/24/17 with swelling and pain and redness of (R) upper arm at injection site and from shoulder to elbow. Arm red, tender and warm. Examined on 5-25-17 - Tx with KEFLEX and BENADRYL.
Full body hives noted within 10-15 minutes of receiving vaccines.; This case was retrieved during the Reporting System monitoring on 12-JAN-2023 with the following. The original narrative from the sender is the following:  Full body hives noted within 10-15 minutes of receiving vaccines. Pt still in the office so brought back to exam room for further evaluation. No wheezing, resp distress, vomiting, or diarrhea associated. Pulse ox 99%. Given Benadryl 0.5 mg/kg once. Observed for 1 hour following vaccines with improvement in hives noted. Did also have new formula on day of vaccine/hives.  The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event, "Urticaria".  No further information is expected.
Woke up at 3am with horrible headache- vomiting and chills.  Headache was so bad that regular migraine medicine didn?t help. Had to call neurologist for pain medication.  Felt sick for 3 days.   8-9 days after vaccine arm became very sore and developed a large red welt at injection site . Pain radiating to finger randomly .  Redness is slowly fading but still have a faint mark
Sore arm almost immediately, lightheadedness for a few hours, then onset of severe headache, body ache and shaking chills.  Improved with Tylenol.  Today still achy but I've continued the Tylenol.
Patient reported no ill effects from the vaccine.  Report is being completed only because it was administered to a child under the approved age limit.
First shot of Lymerix on 5/13/99, 6/99 and 7/99. Immediately, had flu-like symptoms, lung problems, swollen glands, nausea, dizziness and fever on and off since until now. Dx'd with RA. I have since been declared disabled because I can hardly walk and am in constant pain. I am always sick and was in perfect health up until I had Lymerix.  I never had Lyme Disease.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On unknown dates, the patient's were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # L004754, expiry date 10-NOV-2016; dose and route were not reported). No adverse effects were reported. Additional information has been requested.
A non-serious spontaneous report of 13 week pregnant woman received a dose of H1N1 LAIV was received from a physician concerning a 39-year-old female. The patient's medical history and obstetrical history was not reported. The patient was 13 weeks pregnant at the time of event. The expected delivery date was approximately 09-Jun-2010. Concomitant medications have not been reported. On 02-Dec-2009, the patient received H1N1, Intranasal for an unknown indication. There was no adverse event associated with this pregnancy. Treatment and reporter causality assessments were not applicable. The outcome of vaccine exposure during pregnancy was considered resolved. Additional information was received on 11-Jan-2010 and incorporated into the narrative: Expected Delivery Date. Other additional information received: reporter's address.
HR 147, stayed 140s aprox 10 min; Not feeling well; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the parent.  A 9 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 08Dec2021 (Lot number: FK5127) at the age of 9 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU VACCINE VII. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FL0007, Location of injection: Arm Left, Vaccine Administration Time: 06:30 PM, Route of Administration: Intramuscular), administration date: 2021, for COVID-19 immunization, reaction(s): "Feeling "weird" in chest", "HR 140s", "Diaphoretic". The following information was reported: HEART RATE INCREASED (non-serious) with onset 2021, outcome "recovering", described as "HR 147, stayed 140s aprox 10 min"; MALAISE (non-serious) with onset 2021, outcome "recovering", described as "Not feeling well". The events "hr 147, stayed 140s aprox 10 min" and "not feeling well" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of heart rate increased, malaise.  Additional information: patient took other vaccine in four weeks, no other medications the patient received within 2 weeks of vaccination, approx. 2 weeks after 1st dose, approx. 7 days of episodes 1-2 a day. On 3rd day of occurrence went to ED. D/c home, episode occurred for few more nights then stopped. Approx. 24 hrs. after 2nd dose (withheld) complained of, pulsox applied, No chest pain, no SOB, afebrile, nothing else remarkable. No Covid prior vaccination.  No follow-up attempts are possible. No further information is expected.
vertigo; This is a spontaneous report from a contactable consumer (patient's mother-in-law). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: not reported, expiration date: not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced vertigo. Clinical outcome of the event was reported as unknown.  The lot number for BNT162B2 was not provided and will be requested during follow up.  Follow-up activities closed. Batch/lot number not available for [Vaccine BNT162B2].
Itching, Reddened skin, shortness of breath, swelling eyes, lips, fingers, within 15 minutes of receiving shot took PO BENADRYL.  Then saw medical doctor-given KENALOG IM and MEDROL dose pack.
My chest became tight. I took my Salbutamol (2 puffs with my chamber).  Chest became tighter and repeated my Salbutamol.  Woke up twice during the night needing my rescue inhaler again.  Coughing up mucous now which I never do.  Chest is extremely tight and crackly.    My Salbutamol is only working for approx 4 hrs max and cannot inhale as well as I could prior.   I am at 250L/min with my Peak Flow meter whereas the last 3 months I have improved from 250 up to 450.  I?ve been between 400-450 for approx 3 months and have no had a setback until yesterday.
Panic attacks and blood pressure fluctuation for 3 months following the vaccine. This occurred for two years in a row, one or two days following the vaccine. Nothing was found by my cardiologist or a mental health professional. The attacks and Blood pressure fluctuations that caused dizziness and absence from work lasted for about 3month following and then resolved on their own.
Chills; feeling out of it; fatigue; body aches; Dose Number: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 33 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 21Dec2021 19:45 (Batch/Lot number: unknown) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 2, single. Lot No: Unknown. ), for Covid-19 immunization; Bnt162b2 (Dose 1, single. Lot No: Unknown.), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 21Dec2021 19:45, outcome "unknown", described as "Dose Number: 3"; CHILLS (non-serious) with onset 22Dec2021, outcome "recovering", described as "Chills"; FEELING ABNORMAL (non-serious) with onset 22Dec2021, outcome "recovering", described as "feeling out of it"; FATIGUE (non-serious) with onset 22Dec2021, outcome "recovering", described as "fatigue"; PAIN (non-serious) with onset 22Dec2021, outcome "recovering", described as "body aches". Therapeutic measures were taken as a result of chills, feeling abnormal, fatigue, pain.  Additional information: Known allergies was none. No Covid prior vaccination and post vaccination. AE treatment was Tylenol.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Information has been received from a registered nurse concerning a 16 year old female with no medical history and allergies and 0 previous pregnancies, who on 30-OCT-2008 was vaccinated with a 0.5 mL first dose of GARDASIL vaccine (lot #661530/0575X), intramuscularly. Concomitant therapy included ALESSE. On 30-OCT-2008 the patient discovered that she was pregnant, the nurse mentioned that the LMP was 18-NOV-2008, but the patient had an abnormal cycle and the LMP may had been a month earlier. Laboratory diagnostics studies performed include a urine pregnancy test on 18-DEC-2008 at the office, a pre-natal blood work drawn on 23-DEC-2008 (results pending) and a prenatal ultrasound scheduled for next week. Clonazepam (dates taken 20-OCT-2008 for 2 days), PREDNISONE (dates taken 22-NOV-2008 for 3 days) and chlorpromazine (dates taken 20-OCT-2008 for 2 days) were taken by the patient. No adverse effects reported. The patient sought medical attention through an office visit. follow up information received on 27-JAN-2009 from an initial pregnancy questionnaire stated that the patient had recurrent hiccups. Concomitant therapy included MENACTRA. CHLORPROMAZINE (25-NOV-2008 to 28-NOV-2008, 25 mg 3/day). PREDNISONE (22-NOV-2008 to 25-NOV-2008, 20 mg x 2 daily) and CLONAZEPAM (20-NOV-2008 to 22-NOV-2008, 0.25 mg 0.5 mg 2 x day) were taken by the patient for hiccup syndrome. On 07-JAN-2009 the patient had an ultrasound performed for dating, the fetal heart rate was 135; 1 weeks 0 days. The estimated delivery date was 26-AUG-2009 (previously reported 25-AUG-2009). Additional information has been requested.
bone pain; swelling in the injection site; soreness in his arm; tiredness/ Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone pain), VACCINATION SITE SWELLING (swelling in the injection site), MYALGIA (soreness in his arm), FATIGUE (tiredness/ Fatigue) and CHILLS (chills) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062e21a) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Aug-2021, the patient experienced BONE PAIN (bone pain), VACCINATION SITE SWELLING (swelling in the injection site), MYALGIA (soreness in his arm), FATIGUE (tiredness/ Fatigue) and CHILLS (chills). At the time of the report, BONE PAIN (bone pain), VACCINATION SITE SWELLING (swelling in the injection site), MYALGIA (soreness in his arm), FATIGUE (tiredness/ Fatigue) and CHILLS (chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
2:00am 100.1 fever, aches, headache, chills 10:00am-6:00pm 101-102 fever w Advil, aches, headache, chills, tiredness. Unable to do daily activities.  6pm 99.1 fever
This spontaneous report was received from a pharmacist refers to a 71 year old female patient with no drug allergies. Current condition included rheumatoid arthritis. On 12-JUL-2013 the patient was vaccinated with 0.65 milliliter (ml) ZOSTAVAX (lot # J000435 and expiration date 10-APR-2014, route not reported) in the left arm. Concomitant therapies included METHOTREXATE 15 milligram (mg) weekly by mouth (orally), AMARYL and SIMVASTATIN tablets, USP. Pharmacist stated that patient reported developing redness at the time of injection and on 29-JUL-2013 patient reported back to the pharmacy with redness "about the size of a quarter" at site where ZOSTAVAX was administered. Pharmacist stated that there was no heat at the site of injection, "did not appear infected, just red". No treatment was provided for the event. No laboratory diagnostic studies were performed. The outcome of redness at the site of injection was unknown. Causality was not reported. Additional information is not expected.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age. The patient was vaccinated with an expired dose of RECOMBIVAX HB (lot# 666186/1483Y, Expiration Date: 10-SEP-2012) intramuscular on 13-SEP-2012. The reporting nurse noted this was the first dose in the RECOMBIVAX HB vaccination series for this patient. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. At the report time the outcome of event was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
I had something that looked like Sever Chapped lip on my upper lip, looking like red blotches that do not go away.  Saw Dermatologist on 2/6/2023 and they took a culture of this due to a prior staph infection to rule that out.  It was not staph.  Doctor recommended taking a hydrocortisone cream and to take doxycycline which has caused the clear up.  Situation is clearing up and is not visible any more at time of reporting while still taking antibotic.